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SUMMARY
A new conglomerate family sample of 194 dwellings with 996 resident persons were studied in the town of Barcelos, State of
Amazonas, in order to re-evaluate the risk of Chagas disease. During the survey the persons were interviewed and in this occasion we
showed to them a collection of Panstrongylus, Rhodnius and Triatoma, asking if they recognized and eventually have been bitten by
this kind of bugs. At this time we collected 500 ul of blood in microtainer	 tubes from 886 interviewed persons who gave permission
after informed consent. A screening test for T. cruzi antibodies based on agglutination of colored polymer particles, sensitized with
three different synthetic peptides of T. cruzi (ID-PaGIA Chagas Test)	, showed 13.2% of sera positivity, but only 6.8% were confirmed
by indirect immunofluorescence, and ELISA with purified T. cruzi antigens. Two hundred and six interviewed persons (20.7%)
recognized the triatomines, as “piaçavas’ lice” and 62 (30%) confirmed that have been bitten by the bugs, 25.8% of them had a
positive serology for T. cruzi infection. Electrocardiographic alterations were shown in 9.3% of the seropositives and in 11.9% of the
seronegative cases. This was considered not statistically significant.
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INTRODUCTION
Chagas disease has always been considered a sylvatic enzootic in
Brazilian Amazon, until the first human cases were described, in 196949.
Since then, a number of human cases have been reported as consequence
of microepidemics, isolated cases or described through serological
surveys4,13,14,16,19,20,29,32,35,36,44,48,50,51,52,53,57,58,59,60.
Since Carlos Chagas11 has confirmed as Trypanosoma cruzi, the
parasites isolated from Saimiri sciureus by Aben-Athar, many reservoirs
of the parasite were described in the Amazonian
region6,7,21,22,23,24,25,26,33,37,47,61. On the other hand, at least 16 species of
triatomines, 10 of which infected with T. cruzi, were identified on that
region1,2,5,7,8,27,38,39,40,41,42,43,46,55,61.
The risks of endemization of Chagas disease in the Amazonian region
are related to deforestation and to the possible adaptation of sylvatic
triatomines to human dwellings; or, yet, to the transposition of the
domestic cycle from endemic areas to the Amazonian region, due to
migration of infected people and/or to the carriage of vectors and domestic
reservoirs from the endemic areas to that region3,7,12,17,18,34,55.
A national serological survey about the prevalence of Chagasic
infection, accomplished by SUCAM, today Fundação Nacional de Saúde
(National Health Foundation), from 1975 to 1980, indicated a prevalence
of 1.88% in the State of Amazonas10, with a concentration of 6.3 – 6.8%
in areas of Rio Negro51. In 1977, six autochthonous cases sera positive
were registered in Barcelos32 and, in 1985, one acute case of combined
infection by T. cruzi and T. rangeli was described in the same region53.
From 1991 on, we have accomplished various serological surveys
and sectional studies in the town of Barcelos and among the riverside
population of Rio Negro and its affluents Aracá, Curudurí, Padaurí and
Preto. These studies have revealed a high serological prevalence of
Chagasic infection, PCR positiveness and isolation of T. cruzi and T.
rangeli, particularly among workers of piaçava’s gathering and their
families, as well as among sylvatic reservoirs and vectors of the
region13,14,15,16,17,19.
The present study re-evaluates the prevalence of Chagasic infection
within a sample of residents in the town of Barcelos, in middle Rio
Negro. It was used a new technique of polymer particles agglutination,
sensitized by three different T. cruzi peptides (ID-PaGIA Chagas Test	)45,
as a screening test, and its confirmation by indirect immunofluorescence
and ELISA reactions, with purified T. cruzi antigens from
Biomanguinhos, Fiocruz. The study evaluates the risks of Chagasic
infection transmission through the contact of the population with sylvatic
triatomines, as well as disease morbidity, through comparison of
electrocardiograms of sera positive and sera negative individuals for
infection by Trypanosoma cruzi.
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In this article was evaluated the specificity of the ID-PaGIA Chagas
Test	 for field work in the Amazon conditions, where the serology is
usually complex, due to the possibility of cross reactions with other
infections. On the other hand complementing our previous descriptive
works14,19 was carried-out a cross sectional controlled clinical and
epidemiological study to evaluate the risk factors for Chagas disease in
the area, amplifying the sample.
MATERIALS AND METHODS
Area localization: The administrative center of the district of
Barcelos is located on the right riverside of middle Rio Negro, 304 miles
away from Manaus, capital of the state of Amazonas, considering fluvial
way. The district is situated in the microregion of Rio Negro, north of
the state; it limits in east with the state of Roraima, in south and southeast
with the district of Novo Airão and Marãa, in west with the district of
Santa Izabel and in north with Venezuela (0o 58’1” south equatorial
latitude and 62o 56’ west Greenwich longitude) (Fig.1).
Sample and kind of study: It was made a cross sectional study
with a systematic conglomerate family sample, considering one of each
four inhabited dwellings of the town of Barcelos; what represented nearly
25% of the town’s resident population. Schools, churches, public and
commercial buildings were not considered for the study.
At first, a survey was made in order to register the number of inhabited
dwellings and inhabitants of the six Barcelos’ town districts. The town
was distributed according to population concentration degree: Centro,
São Francisco, São Lázaro, São Sebastião, Aparecida and Nazaré.
Then, in a more systematic way, each sample dwelling was visited
by two doctors, who explained the objectives of the study to the family
and obtained their permission for the survey.
Material and information collection: Two questionnaires were
applied, one for the dwelling and the other for each individual, in order
to analyze the population epidemiological and previous clinical
conditions. The first questionnaire, directed to the family leader or, in
his absence, to any member of the family able to answer it, had the
objective to evaluate the physical and sanitary conditions of the dwelling:
water supply, waste and sewage disposal, lightening and material goods,
what indicates the economical level of the family. The individual
questionnaire was directed to all family members (if there were minor
children, the parents answered for them) and was constituted by an
anamnesis about previous conditions, specially those related to risk
factors for Chagasic infection, as: occupation, recognition of triatomines,
possibility of having been bitten by the bugs, previous history of surgery
and blood transfusion. Everyone was shown a collection of triatomines,
formed by Pantrongylus, Rhodnius and Triatoma exemplars, and asked
if they were able to recognize the bugs.
From every interviewed person over two years old, at the time of the
first visit or later, it was collected 500 ul of blood by finger puncture,
into Microtainer® tubes (Beckton Dickson)® with sera separator gel, for
serological reactions.
Laboratory procedures: The blood collected into the Microtainer®
was centrifuged in 500 G, for 10 minutes; after that, 25 ul of serum was
extracted and transferred, through an automatic pipette with an individual
point for each serum, to one of the six microtubes of the ID Chagas Test
kit, with the red colored polymer particles, sensitized with three different
synthetic peptides of T. cruzi antigens, previously homogenized. The
combination of the serum and the polymer particles was incubated at
room temperature, for 15 minutes; then, it was centrifuged in a special
equipment for the kit, for 15 minutes more, according to the fabricant
instructions. For each group, it was added a control serum positive, and
another one, negative. In the positive considered sera, it was formed a
red line on the top, as consequence of the adherence occurred between
the particles and the antibodies; in the negative ones, a precipitate was
formed on the microtube’s bottom, after the centrifugation (Fig. 2). The
sera considered positive, according to this technique, and a sample of
the negative ones were tested afterwards by the indirect immuno-
fluorescence reaction and by ELISA with purified soluble antigens,
Fig. 1 - District of Barcelos in the microregion of Rio Negro, State of Amazonas
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obtained through the culture of T. cruzi, produced by Biomanguinhos
(Fiocruz).
Clinical and epidemiological procedures: Individuals with positive
serology according to the screening method (ID-PaGIA Chagas Test)
were paired with others of the same age and sex. On a second home
visit, the 886 patients submitted to the screening test received the
serological results and the 117 pairs (positive and negative) were invited
to go to the local hospital, to be submitted to clinical and electro-
cardiographic exams, by the authors; also, their blood were collected
through venous puncture in a vacutainer tube for confirming serological
exam (by indirect immunofluorescence and ELISA with purified T. cruzi
antigens), hemoculture, indirect xenodiagnosis and PCR, since the
patients agreed with exams and blood collection, after informed consent.
RESULTS
Sample and population characteristics: The conglomerate family
sample was constituted of 194 dwellings, where lived 996 persons: an
average of 5.1 inhabitants for each dwelling. There were 442 (44.4%)
males and 554 (55.6%) females. The distribution by age and sex (Table
1) shows that 56% of population are under 20 years old. Most of them
are crosbred (caboclos), 30.5% are white and only 0.2% are black.
The occupational analysis indicates that 33.4% were students, 17.4%
worked at home and 13.3% were under five years old. Among the
economical active population, commerce was the main activity (4.7%),
followed by domestic work (3.9%), agriculture (2.8%), teaching (2.1%),
public service (2.1%), extracting (2%) and fishing (1.9%); only 2.5%
were retired; 8.6% had various activities and 5.3% had no defined
occupation.
Risk factors for Chagas disease: During the individual
questionnaires, people were shown a collection of triatomines and 206
individuals (20.7%) recognized at least one of the bug species. Most of
them (67.5%) saw the bugs at piaçava’s palm trees; 36.4% of these
worked on the extractive process of piaçava (Leopoldinia piassaba) and
the others were the workers’ family members or companions (Fig. 3).
Among the triatomines, the Rhodnius was mostly identified (60.7%).
From the 206 individuals who identified the triatomine, 62 (30%) told
that had already been bitten by the bug, mostly in a piaçava’s growing
area. Among the individuals bitten by the bug, 25.8% had positive
serology for T. cruzi infection, while among the ones who had not been
bitten, only 11.7% had positive serology (p = 0.03); what indicates a
positive association between contact with triatomine and positive
serology.
Table 1
Distribution by age group and sex of population sample from Barcelos,
State of Amazonas
Sex Total
Age group Female Male
(years) (N) (N) (N) (%)
0 – 10 154 136 290 29.1
11 – 20 146 121 267 26.8
21 – 30 84 62 146 14.7
31 – 40 66 40 106 10.6
41 – 50 45 29 74 7.4
51 – 60 27 18 45 4.5
> 60 32 36 68 6.8
Total 554 442 996 100.0 Fig. 3 - Piaçavas’ workers and their families outside the huts in the work place
Fig. 2 - ID – PaGIA Chagas Test kit with positive and negative reactions
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Considering all interviewed individuals, 86 had been submitted to a
surgery; 19 of them (2.2%) received blood transfusion during the surgery
and 15 received blood transfusion for other reasons, what sums 34
individuals who received blood for some reason. In this case, there were
no association between blood transfusion and positive serology.
From the 886 persons considered in the sample who agreed with
blood collection for serological exam, 117 (13.2%) were positive,
according to the ID-PaGIA Chagas Test trial (Table 2); however, only
6.8% were confirmed, by indirect immunofluorescence and ELISA; from
92 sera negative by ID-PaGIA Chagas Test, 4 (4.3%) were positive, by
indirect immunofluorescence and ELISA, showing a low specificity of
ID-PaGIA Chagas Test for T. cruzi antibodies for this lot of sera from
Amazonas.
Ninety five percent of the population sample were autochthonous
from the Amazonas State and 80% from the Rio Negro area. Only 5%
were from other states and none of them had positive serology for Chagas
infection; there was no difference or city clusters in relation to
seropositivity. From 18 children younger of 10 years old with screening
test (ID-PaGIA) positive for T. cruzi antibodies (Table 2) none had mother
with positive serology for Chagas infection. The ages of the patients
parasitologically positive are, respectively, 15, 23 and 59 years old.
Xenodiagnosis, hemoculture and PCR: From the 74 indirect
xenodiagnosis of patients with positive screening serology, using 40
Triatoma infestans and/or Panstrongylus megistus nymphs of 3rd/4th stage,
only one (1.35%) was positive for T. cruzi, while in the 98 hemocultures
made in LIT medium, also only one (1%) was positive. The polymerase
chain reaction (PCR) done in 101 samples showed positive for three
(2.97%) of them. A single patient (23 years old) had xenodiagnosis,
hemoculture and PCR positive and two other had only a PCR positive.
The isolated strain was characterized as Z3 by analysis enzyme
electrophoresis and also by typing mini-exon gene.
Clinical and electrocardiographic exam: The clinical and
electrocardiographic exams that have been done in 106 patients with
positive serology for Chagasic infection and in 87 negative controllers,
who answered the invitation to come into the hospital, did not show any
significant difference, neither any indication of morbidity for Chagas
disease. Independently of positive or negative serology, it was observed
eight cases of first degree right bundle branch block (4.1%), seven cases
of left ventricular overload (3.6%), four cases of left anterior hemiblock
(2%) and some alterations of less importance, not related to heart
pathology.
DISCUSSION
The high prevalence of sera positive reactions after screening tests
(13.2%), which was observed in the agglutination reactions with ID-
PaGIA Chagas Test, confirms previously observed results of 12.5% and
13.7%, at the same area, with immunofluorescence14,19; this fact may be
related to the presence of cross reactions with heterophile antibodies,
EVI (anti-Gal) type, laminin and others, that may induce cross reactions
with natural antibodies anti-T. cruzi (reviewed by BRENER, 1992 and
STOLF, 1992)9,54; the cross reaction may be induced by diverse infections,
including those caused by Leishmania sp and others kinetoplastida.
Similarly, we have observed that, even in the case of ELISA reactions
with purified (Biomanguinhos) and recombinant (CRA and FRA) T. cruzi
antigens, it may occur cross reactions with sera from that region; possibly
caused by the same mechanisms, previously mentioned. The ID-PaGIA
Chagas Test	 used as screening test for our lot or sera from Amazon,
showed a very low specificity compared with results obtained by other
authors45 with lots of sera from traditional endemic areas for Chagas
disease in Brazil.
Immunoblotting with trypomastigote excreted-secreted antigens
(TESA-blot) of Trypanosoma cruzi carried out on 401 chagasic patients
from different areas in Brazil, chronic, acute and congenital cases, and
111 non chagasic, included 30 cases of visceral and cutaneous
leishmaniasis, showed a specificity index of 1,000 and no cross-
reactions56. In this survey we found three cases with positive PCR for T.
cruzi (2.97%), among the 101 analyzed, what leads us to infer that the
prevalence of the infection by the parasite has, at least, the same level.
Studies in progress using TESA-blot as confirmatory test for conventional
serology for Chagasic infection, have indicate that the prevalence of the
infection in our work area in the Amazon vary from 2% to 5%, depending
on the intensity of the contact of the population with sylvatic triatomines.
In this study, 20.7% of the interviewed persons recognized the
triatomine; 60.7% of these, identified the Rhodnius brethesi as the
“piaçava’s lice” (Fig. 4), as they call this species of triatomine in that
region. Besides, 30% of the individuals who identified the triatomine
affirmed that they had already been bitten by the bug; what is a strong
evidence of the risk of Chagasic infection vectorial transmission in that
region, specially among individuals who gathers piaçava (Leopoldina
piassaba) and their family members. We have confirmed this fact when
we described the sylvatic triatomines’ attack to human population, in
that region15. In the other hand, despite of the serological reactions
fragility due to the possibility of cross reactions, the fact that 25.8% of
the individuals bitten by the triatomines presented positive serology –
against 11.7% of the not bitten ones – indicates a close association
between contacting triatomine and positive serology.
The low morbidity of chagasic infection at the studied area, already
indicated in previous work19 and confirmed in this one, may be related
to the low rates of parasitemia, shown through xenodiagnosis,
Table 2
Serologic screening test with ID – PaGIA Chagas Test and % of confirmed by
IF + ELISA. Barcelos, State of Amazonas
Age group Total examined ID-PaGIA Positives % Confirmed
(years) (N) (%) (N) (%) IF + ELISA
> 2 – 10 146 16.5 18 10.6 5.5
11 – 20 255 25.4 41 16.1 7.3
21 – 30 139 15.7 28 20.1 7.1
31 – 40 100 11.3 15 15.0 6.6
41 – 50 69 7.88 4 5.8 -
51 – 60 43 4.9 5 11.6 20.0
> 60 65 7.4 6 9.2 16.6
Total 886 100.0 117 13.2 (*) 6.8
(*) Not excluded cross-reations. Only 6.8% were confirmed by indirect
immunofluorescence (IF) and ELISA.
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hemoculture and PCR, or to the typical kind of parasite that circulates in
the region. Recent studies developed by our group30,31, in collaboration
with other ones, indicate intra/inter-specific differences between sylvatic
strains of Trypanosoma cruzi typical of the region and domestic strain
characteristic of endemic areas. Classified as T. cruzi I (sylvatic) and T.
cruzi II (domestic), they may induce several antigenic stimuli and
important morbidity differences, at least during disease’s chronic phase,
as demonstrated in previous works.
Chagas disease in the Brazilian Amazon represents a special chapter
within the researches dedicated to this disease, and includes the etiological
agents, reservoirs, vectors and, specially, the parasite-host relationship
and the risks of disease endemization, which should be deeply studied.
A new serological survey for Chagas disease in the Brazilian Amazon
has been planned by the Ministry of Health to start in 2002. In addition,
during the Fifth Meeting on Diagnostic, Treatment and Control of
Tropical Diseases of the low Amazon it was proposed an agenda priorities
for researches on Chagas disease in the Amazon region28.
RESUMO
Doença de Chagas na Amazônia brasileira. IV. Um novo estudo
seccional
Um novo estudo de um conglomerado familiar de 194 domicílios
com 996 pessoas residentes na cidade de Barcelos, Estado do Amazonas,
foi feito a fim de re-avaliar o risco da doença de Chagas. Durante o
inquérito as pessoas foram entrevistadas e nesta ocasião lhes foi mostrada
uma coleção de Panstrongylus, Rodhnius e Triatoma, perguntando-lhes
se reconheciam e se eventualmente tinham sido picados por aquele tipo
de inseto. Nesta ocasião foi coletado 500 ul de sangue em tubos
microtainer	 de 886 pessoas entrevistadas que deram permissão, após o
consentimento informado. Um teste de triagem para anticorpos anti-T.
cruzi foi realizado por um método de aglutinação de partículas de
polímero colorido, sensibilizadas com três diferentes peptídeos sintéticos
(ID-PaGIA Chagas Test)	, mostrou uma soropositividade de 13,2%, mas
somente 6,8% foram confirmados por imunofluorescência indireta e
ELISA com antígenos de T. cruzi purificado. Duzentos e seis pessoas
entrevistadas (20,7%) reconheceram os triatomíneos como “piolho de
piaçava” e 62 (30%) confirmaram terem sido picados pelos insetos,
25,8% delas tiveram a sorologia de triagem positiva para infecção pelo
T. cruzi. Alterações eletrocardiográficas foram verificadas em 9,3% dos
soropositivos e em 11,9% dos negativos, o que foi considerado
estatisticamente não significativo.
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